Trial updateRetina
Safety, Tolerability and Efficacy of Intravitreal KIO-104 in Patients With Macular Edema
Recruiting. Phase 2. Registered enrolment: 28. Kiora Pharmaceuticals, Inc.
Why it matters
Track this study through NCT06825702. No results are posted in this registry record.
The study at a glance
- Registry status
- Recruiting
- Phase
- Phase 2
- Registered enrolment
- 28
- Results posted
- No
- Sponsor
- Kiora Pharmaceuticals, Inc.
Keep in mind
Registry information describes the study; recruitment status alone does not establish efficacy or safety.